These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2159186)
61. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
62. Chemotherapeutic and surgical strategies for germ cell tumors. Einhorn LH Chest Surg Clin N Am; 2002 Nov; 12(4):695-706. PubMed ID: 12471872 [TBL] [Abstract][Full Text] [Related]
63. Clinical trials with ifosfamide: the Indiana University experience. Loehrer PJ; Williams SD; Nichols CR; Einhorn LH Semin Oncol; 1992 Feb; 19(1 Suppl 1):35-9. PubMed ID: 1329210 [TBL] [Abstract][Full Text] [Related]
64. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. Motzer RJ; Sheinfeld J; Mazumdar M; Bains M; Mariani T; Bacik J; Bajorin D; Bosl GJ J Clin Oncol; 2000 Jun; 18(12):2413-8. PubMed ID: 10856101 [TBL] [Abstract][Full Text] [Related]
65. Potential advances in combination chemotherapy for advanced testicular cancer. Kaye SB; Stoter G; Sleijfer D; Jones W; Ten Bokkel Huinink W; Splinter T; Van Oosterom A; Harris A; Boven E; De Pauw M Prog Clin Biol Res; 1988; 269():461-9. PubMed ID: 2455913 [TBL] [Abstract][Full Text] [Related]
66. [Salvage therapy for refractory testicular cancer]. Kawai K; Akaza H Gan To Kagaku Ryoho; 1996 Aug; 23(9):1129-35. PubMed ID: 8751799 [TBL] [Abstract][Full Text] [Related]
67. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A; Biron P; Philip I; Blay JY; Droz JP Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344 [TBL] [Abstract][Full Text] [Related]
68. Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group. Levi JA; Thomson D; Harvey V; Gill G; Raghavan D; Tattersall M; Snyder R; Burns I; Sandeman T; Byrne M J Clin Oncol; 1990 Jan; 8(1):27-32. PubMed ID: 2153192 [TBL] [Abstract][Full Text] [Related]
69. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin. Brada M; Horwich A; Peckham MJ Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041 [TBL] [Abstract][Full Text] [Related]
70. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. Loehrer PJ; Gonin R; Nichols CR; Weathers T; Einhorn LH J Clin Oncol; 1998 Jul; 16(7):2500-4. PubMed ID: 9667270 [TBL] [Abstract][Full Text] [Related]
71. Chemotherapy of refractory germ cell cancer with Etoposide. Lederman GS; Garnick MB; Canellos GP; Richie JP J Clin Oncol; 1983 Nov; 1(11):706-9. PubMed ID: 6321675 [TBL] [Abstract][Full Text] [Related]
72. VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer. Einhorn LH Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S45-50. PubMed ID: 3815718 [TBL] [Abstract][Full Text] [Related]
73. A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Pico JL; Rosti G; Kramar A; Wandt H; Koza V; Salvioni R; Theodore C; Lelli G; Siegert W; Horwich A; Marangolo M; Linkesch W; Pizzocaro G; Schmoll HJ; Bouzy J; Droz JP; Biron P; ; Ann Oncol; 2005 Jul; 16(7):1152-9. PubMed ID: 15928070 [TBL] [Abstract][Full Text] [Related]
74. Ifosfamide in combination chemotherapy for sarcomas and testicular carcinomas. Niederle N; Scheulen ME; Cremer M; Schütte J; Schmidt CG; Seeber S Cancer Treat Rev; 1983 Sep; 10 Suppl A():129-35. PubMed ID: 6627239 [TBL] [Abstract][Full Text] [Related]
75. General Motors Cancer Research Prizewinners Laureates Lectures. Charles F. Kettering Prize. Clinical trials in testicular cancer. Einhorn LH Cancer; 1993 May; 71(10):3182-4. PubMed ID: 8490849 [TBL] [Abstract][Full Text] [Related]
76. Cisplatin and etoposide for metastatic testis cancer in a renal transplant recipient. Vogelzang NJ J Urol; 1990 Jun; 143(6):1235-6. PubMed ID: 2160550 [TBL] [Abstract][Full Text] [Related]
77. Re: Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients with Intermediate- or Poor-Risk Germ Cell Tumors. Richie JP J Urol; 2017 Aug; 198(2):257. PubMed ID: 29370652 [No Abstract] [Full Text] [Related]
78. Salvage chemotherapy in relapsed germ cell tumors. Beyer J; Rick O; Siegert W; Bokemeyer C World J Urol; 2001 Apr; 19(2):90-3. PubMed ID: 11374323 [TBL] [Abstract][Full Text] [Related]
79. Re: First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG). Richie JP J Urol; 2015 Mar; 193(3):850. PubMed ID: 25765390 [No Abstract] [Full Text] [Related]
80. Active chemotherapy for metastatic stromal cell tumor of the testis. Stewart DA; Stewart DJ; Mai KT Urology; 1993 Dec; 42(6):732-4. PubMed ID: 8256409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]